Restor Metabolix, Inc.

Restor Metabolix, Inc. is a medical devices startup founded in January 2021, with a mission to equip physicians with a proprietary treatment option to reverse insulin resistance and repair broken metabolisms. The company is solely focused on partnering with physicians and healthcare organizations to improve the outcomes of their diabetic patients. Through a multi-patented, physician-directed treatment modality, Restor Metabolix has scientifically proven to reverse the underlying causation of most diabetic symptoms and comorbidities: Insulin Resistance. The startup is rapidly expanding this treatment modality to interested physicians who seek alternatives to traditional treatment options for their diabetic patients. Restor Metabolix aims to provide a turn-key solution to help physicians grow their practice. Headquartered in the United States, the company is poised to make a significant impact on the medical industry. For more information, visit their website at www.restormetabolix.com.